Citadel Advisors’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.2M Sell
2,118,400
-97,200
-4% -$1.59M 0.01% 1823
2025
Q4
$28.6M Sell
2,215,600
-96,400
-4% -$1.02M ﹤0.01% 1955
2025
Q3
$19.5M Buy
2,312,000
+2,088,000
+932% +$19.7M ﹤0.01% 2377
2025
Q2
$1.93M Buy
224,000
+86,100
+62% +$639K ﹤0.01% 5765
2025
Q1
$1.19M Sell
137,900
-73,300
-35% -$521K ﹤0.01% 6575
2024
Q4
$1.41M Buy
211,200
+120,300
+132% +$894K ﹤0.01% 6348
2024
Q3
$654K Sell
90,900
-82,900
-48% -$763K ﹤0.01% 7695
2024
Q2
$1.81M Sell
173,800
-69,500
-29% -$694K ﹤0.01% 5518
2024
Q1
$2.45M Sell
243,300
-751,300
-76% -$8.08M ﹤0.01% 5134
2023
Q4
$15.2M Buy
994,600
+470,300
+90% +$6.5M ﹤0.01% 2319
2023
Q3
$7.33M Buy
524,300
+428,600
+448% +$6.48M ﹤0.01% 3087
2023
Q2
$1.27M Sell
95,700
-179,600
-65% -$2.44M ﹤0.01% 5971
2023
Q1
$4.43M Sell
275,300
-101,600
-27% -$1.8M ﹤0.01% 4011
2022
Q4
$5.61M Buy
376,900
+271,500
+258% +$4.73M ﹤0.01% 3660
2022
Q3
$2.1M Buy
105,400
+48,100
+84% +$1.19M ﹤0.01% 5504
2022
Q2
$1.17M Sell
57,300
-95,100
-62% -$2.35M ﹤0.01% 6665
2022
Q1
$4.63M Sell
152,400
-195,200
-56% -$7.63M ﹤0.01% 4321
2021
Q4
$14.2M Sell
347,600
-104,200
-23% -$4.34M ﹤0.01% 2501
2021
Q3
$19.1M Sell
451,800
-15,300
-3% -$757K ﹤0.01% 2064
2021
Q2
$24.6M Buy
467,100
+25,600
+6% +$1.27M 0.01% 1836
2021
Q1
$19.6M Buy
441,500
+10,400
+2% +$513K ﹤0.01% 1983
2020
Q4
$20.7M Buy
431,100
+69,500
+19% +$3.35M 0.01% 1768
2020
Q3
$16.9M Buy
361,600
+254,900
+239% +$12.5M ﹤0.01% 1716
2020
Q2
$4.8M Sell
106,700
-356,100
-77% -$13.8M ﹤0.01% 3148
2020
Q1
$13.5M Sell
462,800
-243,700
-34% -$9.07M 0.01% 1571
2019
Q4
$33.7M Buy
706,500
+393,100
+125% +$17M 0.01% 1037
2019
Q3
$11.9M Sell
313,400
-193,800
-38% -$7.57M 0.01% 2019
2019
Q2
$21.7M Sell
507,200
-146,700
-22% -$6.95M 0.01% 1352
2019
Q1
$34.6M Buy
653,900
+24,600
+4% +$1.41M 0.02% 915
2018
Q4
$37.1M Buy
629,300
+68,100
+12% +$3.76M 0.02% 791
2018
Q3
$30.6M Sell
561,200
-51,600
-8% -$2.85M 0.01% 1073
2018
Q2
$32.9M Sell
612,800
-18,800
-3% -$988K 0.02% 937
2018
Q1
$30.8M Sell
631,600
-211,000
-25% -$8.96M 0.02% 837
2017
Q4
$28.5M Buy
842,600
+35,600
+4% +$1.25M 0.02% 946
2017
Q3
$27.4M Buy
807,000
+20,200
+3% +$691K 0.02% 886
2017
Q2
$28.1M Sell
786,800
-8,400
-1% -$283K 0.02% 795
2017
Q1
$23.1M Sell
795,200
-155,200
-16% -$4.32M 0.02% 851
2016
Q4
$22.9M Buy
950,400
+105,400
+12% +$2.88M 0.02% 777
2016
Q3
$26.2M Buy
845,000
+222,200
+36% +$7.02M 0.03% 713
2016
Q2
$18.2M Sell
622,800
-221,200
-26% -$6.62M 0.02% 841
2016
Q1
$26M Buy
844,000
+519,800
+160% +$13.4M 0.03% 597
2015
Q4
$8.69M Sell
324,200
-732,200
-69% -$20.3M 0.01% 1389
2015
Q3
$28.8M Sell
1,056,400
-788,600
-43% -$21.6M 0.03% 678
2015
Q2
$50.8M Buy
1,845,000
+808,400
+78% +$19.6M 0.04% 490
2015
Q1
$22.2M Sell
1,036,600
-47,000
-4% -$803K 0.02% 923
2014
Q4
$20.4M Sell
1,083,600
-307,400
-22% -$6.58M 0.02% 930
2014
Q3
$30.4M Buy
1,391,000
+286,000
+26% +$7.64M 0.03% 657
2014
Q2
$35.7M Buy
1,105,000
+370,000
+50% +$11.3M 0.04% 513
2014
Q1
$21M Sell
735,000
-485,600
-40% -$16M 0.02% 795
2013
Q4
$48M Sell
1,220,600
-265,200
-18% -$9.19M 0.06% 374
2013
Q3
$51.8M Buy
1,485,800
+845,200
+132% +$26.1M 0.08% 302
2013
Q2
$14.5M Buy
+640,600
New +$13.6M 0.02% 834

Other funds holding HLF

Citadel Advisors's HLF Position: Q1 2026 in Review

Citadel Advisors reduced its Herbalife (HLF) stake by 34% in Q1 2026, selling an estimated $1.83M and leaving 214,320 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5171.

Citadel Advisors first reported a position in HLF in Q2 2013 and has held it in 48 quarters since. The position peaked at $29.3M in Q2 2015. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Citadel Advisors held 214,320 shares of Herbalife worth $3.15M as of Q1 2026.
  • Citadel Advisors sold 111,984 Herbalife shares in Q1 2026, an estimated $1.83M.
  • Herbalife made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5171 holding.
  • Citadel Advisors first reported a position in Herbalife in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Herbalife position peaked at $29.3M in Q2 2015.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.